Technology News and Research

RSS

MicuRx Pharmaceuticals, Cumencor Pharmaceuticals, Pfizer collaborate to develop antibiotics for MDR-TB

MicuRx Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the development of antibiotics to treat drug-resistant bacteria, and Cumencor Pharmaceuticals, Inc. today announced that the companies have entered a collaboration with Pfizer to discover novel therapeutic agents to treat multi-drug resistant tuberculosis.

7 Apr 2010

Lumenis' 2009 revenues down 12% to $226.1M

Lumenis Ltd., a global leader in developing, manufacturing and distributing a broad range of high-end medical lasers and sophisticated energy delivery equipment for surgical, ophthalmic and aesthetic applications, today announced its financial results for the year ended December 31, 2009 and that it has filed its 2009 annual report on Form 20-F with the U.S. Securities and Exchange Commission.

From Lumenis Inc. 7 Apr 2010

IPS examines malnutrition, obesity in Latin America

Inter Press Service examines malnutrition and factors contributing to the rising rates of "obesity and obesity-related illness - such as type II diabetes, high blood pressure, heart disease, some forms of cancer and osteoporosis - in Latin America, and especially among the poorest sectors of the population."

7 Apr 2010

New web-based technology platform for late phase clinical research

PAREXEL International Corporation, a leading global biopharmaceutical services provider, today announced that it has introduced a new web-based technology platform for late phase clinical research to meet the expanding regulatory and commercialization needs of the biopharmaceutical industry.

6 Apr 2010

New study shows utility of Chronix Biomedical's serum DNA tests in MS

Chronix Biomedical today announced publication of a study that supports the utility of its serum DNA blood tests to predict clinical status and monitor disease activity and response to treatment in multiple sclerosis. Chronix Biomedical uses proprietary technology to identify disease-specific genetic fingerprints based on the circulating DNA that is released into the bloodstream by damaged and dying cells.

6 Apr 2010

Src can be most promising targets for cancer therapy

Src (short for sarcoma) is a family of proto-oncogenic tyrosine kinases active in many cancer tumors, including medulloblastoma, the most common malignant cancer in children. Src represents one of the most promising targets for cancer therapy.

6 Apr 2010

SANUWAVE Health announces completion of patient enrollment in dermaPACE Phase III clinical trial

SANUWAVE Health, Inc., an emerging medical technology company focused on the development and commercialization of non-invasive, biological response activating devices in the regenerative medicine area, today announced that patient enrollment was completed in March in its dermaPACE™ Phase III pivotal, randomized, double-blinded, sham controlled, multicenter clinical trial comparing its Pulsed Acoustic Cellular Expression technology, utilizing the dermaPACE™ tissue regeneration device, to sham control for the treatment of diabetic foot ulcers.

6 Apr 2010

Sinovac Biotech's fourth-quarter sales increase 194%

Sinovac Biotech Ltd., a leading China-based vaccine manufacturer, announced today its unaudited financial results for the three-month and preliminary twelve-month periods ended December 31, 2009.

6 Apr 2010

New head-mounted display system lets anesthesiologists focus on monitoring data during surgery

A new head-mounted display system lets anesthesiologists keep an eye on critical monitoring data during surgery—without having to turn their attention away from the patient, reports a study in the April issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society.

6 Apr 2010

DLVSC offers Zeltiq procedure to freeze away unwanted fat cells

Zeltiq™, an innovative technology that freezes away unwanted fat, is now available at Dermatology, Laser and Vein Specialists of the Carolinas – making DLVSC one of the first medical practices in the Southeast to offer this breakthrough in fat reduction.

6 Apr 2010

University of Wisconsin-Madison uses ultrasensitive detector to find fetal heart rhythm problems

At the University of Wisconsin-Madison, one of the most powerful magnetic detectors in the world is helping screen high-risk pregnant patients for rare but very serious fetal heart rhythm problems. Thanks to a collaboration with The Medical College of Wisconsin, Milwaukee; Children's Hospital of Wisconsin, Milwaukee; and Hope Children's Hospital, Chicago, the ultrasensitive detector measures magnetic signals coming from the tiny beating hearts of fetuses.

6 Apr 2010

TAP to showcase performance of Fill-It dispensing system at SBS Conference

The Automation Partnership, a world leader in the design and development of innovative automation for life science applications, announces it will be showcasing the performance of its Fill-It™, benchtop automated dispensing system with a fun "Man versus Fill-It Challenge" on Booth 517 at the Society of Biomolecular Screening Conference, on April 11-15.

6 Apr 2010

MHS to deploy NextGen EHR and NextGen HIE management solutions

NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc. and a leading provider of healthcare information systems and connectivity solutions, today announced an agreement with Mercy Health System to deploy NextGen® EHR and NextGensm Health Information Exchange.

6 Apr 2010

Oncologists to provide overview on new neuro-oncology guidelines

John Theurer Cancer Center at Hackensack University Medical Center will bring together top neuro-oncologists from around the country for an all day symposium to address new treatment updates and review management of complex cases across a broad array of neuro-oncology specialties.

6 Apr 2010

ITI to lead multi-university consortium to improve patient outcomes

The U.S. health care community has increasingly been adopting the use of electronic medical records and other electronic health information systems, but serious concerns about the security and privacy of those systems have been raised.

6 Apr 2010

Next phase of health reform in the U.S. to focus on individualized care: PwC

The next phase of health reform in the United States will reflect a concerted effort to keep people well, out of the hospital and more actively engaged in managing their own health, according to PricewaterhouseCoopers LLP.

6 Apr 2010

Sechrist Industries to design 1000th Model 3200 monoplace hyperbaric chamber

The one-thousandth Model 3200 monoplace hyperbaric chamber to be designed and manufactured by HBO leader, Sechrist Industries, will be delivered to the Medical Center of Plano in Plano, Texas. The milestone, achieved by no other hyperbaric technology company, attests to the increasing demand for hyperbaric oxygenation in a wide variety of indications.

6 Apr 2010

EPO upholds Nabi Biopharmaceuticals' opposition to Drug Abuse Therapy patent

Nabi Biopharmaceuticals announced today that the European Patent Office upheld the Company's opposition to European Patent No. 1,329,226 (Hapten Carrier Conjugates for Use in Drug Abuse Therapy) requesting revocation of this patent. The EPO revoked this patent in its entirety.

6 Apr 2010

People with disabilities to attend Abilities Expo at the Los Angeles Convention Center

Thousands of people with disabilities, their families, caregivers, seniors, veterans and healthcare professionals are expected to attend Abilities Expo on Friday, April 9, through Sunday, April 11, 2010 at the Los Angeles Convention Center. Admission is free and show hours will be Friday 11 am to 5 pm, Saturday 10 am to 5 pm and Sunday, 11 am to 4 pm.

6 Apr 2010

Ascom introduces new VoIP solution for healthcare sector

Ascom Wireless Solutions, the leading supplier of on-site communications, introduces VoIP (Voice over Internet Protocol) to their teleCARE IP solution, a system already established at hospitals and care homes across the world.

6 Apr 2010